These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 9307472

  • 21. 18FDG-PET-CT improves specificity of preoperative lymph-node staging in patients with intestinal but not diffuse-type esophagogastric adenocarcinoma.
    Lehmann K, Eshmuminov D, Bauerfeind P, Gubler C, Veit-Haibach P, Weber A, Abdul-Rahman H, Fischer M, Reiner C, Schneider PM.
    Eur J Surg Oncol; 2017 Jan; 43(1):196-202. PubMed ID: 27692533
    [Abstract] [Full Text] [Related]

  • 22. Clinical significance of ¹⁸F-fluorodeoxyglucose positron emission tomography in superficial esophageal squamous cell carcinoma.
    Kita Y, Okumura H, Uchikado Y, Sasaki K, Omoto I, Matsumoto M, Setoyama T, Tanoue K, Mori S, Owaki T, Ishigami S, Ueno S, Kajiya Y, Natsugoe S.
    Ann Surg Oncol; 2013 May; 20(5):1646-52. PubMed ID: 23238695
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations.
    van Westreenen HL, Heeren PA, van Dullemen HM, van der Jagt EJ, Jager PL, Groen H, Plukker JT.
    J Gastrointest Surg; 2005 Jan; 9(1):54-61. PubMed ID: 15623445
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
    Avril N, Dose J, Jänicke F, Ziegler S, Römer W, Weber W, Herz M, Nathrath W, Graeff H, Schwaiger M.
    J Natl Cancer Inst; 1996 Sep 04; 88(17):1204-9. PubMed ID: 8780629
    [Abstract] [Full Text] [Related]

  • 28. Discovery of the primary site of esophageal squamous cell carcinoma based on axillary lymph nodes metastasis detected with fluorodeoxyglucose positron-emission tomography: report of a case.
    Hagiwara N, Matsutani T, Nomura T, Miyashita M, Yamashita N, Wachi E, Uchida E.
    J Nippon Med Sch; 2014 Sep 04; 81(6):395-400. PubMed ID: 25744485
    [Abstract] [Full Text] [Related]

  • 29. Imaging features of primary and recurrent esophageal cancer at FDG PET.
    Skehan SJ, Brown AL, Thompson M, Young JE, Coates G, Nahmias C.
    Radiographics; 2000 Sep 04; 20(3):713-23. PubMed ID: 10835124
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
    Kato H, Kuwano H, Nakajima M, Miyazaki T, Yoshikawa M, Ojima H, Tsukada K, Oriuchi N, Inoue T, Endo K.
    Cancer; 2002 Feb 15; 94(4):921-8. PubMed ID: 11920459
    [Abstract] [Full Text] [Related]

  • 32. Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer.
    Flamen P, Van Cutsem E, Lerut A, Cambier JP, Haustermans K, Bormans G, De Leyn P, Van Raemdonck D, De Wever W, Ectors N, Maes A, Mortelmans L.
    Ann Oncol; 2002 Mar 15; 13(3):361-8. PubMed ID: 11996465
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Clinical Significance of [18F] Fluoro-2-Deoxy-d-Glucose/Computed Tomographic Avid Hilar Lymph Nodes in Esophageal Carcinoma Patients.
    Feldman HA, Erasmus JJ, Zhou N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WL, Betancourt Cuellar SL.
    Ann Thorac Surg; 2022 Oct 15; 114(4):1183-1188. PubMed ID: 34634240
    [Abstract] [Full Text] [Related]

  • 35. [18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?
    Halter G, Buck AK, Schirrmeister H, Wurziger I, Liewald F, Glatting G, Neumaier B, Sunder-Plassmann L, Reske SN, Hetzel M.
    J Thorac Cardiovasc Surg; 2004 Apr 15; 127(4):1093-9. PubMed ID: 15052207
    [Abstract] [Full Text] [Related]

  • 36. [FDG PET/CT versus PET alone for pre-surgical detection of lymph node metastasis in esophageal carcinoma].
    Yuan SH, Yu JM, Yu YH, Fu Z, Guo HB, Liu TH, Yang XH, Yang GR, Li WW.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar 15; 29(3):221-4. PubMed ID: 17649642
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial.
    Veeramachaneni NK, Zoole JB, Decker PA, Putnam JB, Meyers BF, American College of Surgeons Oncology Group Z0060 Trial.
    Ann Thorac Surg; 2008 Aug 15; 86(2):418-21; discussion 421. PubMed ID: 18640307
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.